p53 and cancer therapy: a double-edged sword
J Clin Invest
.
1999 Aug;104(3):223-5.
doi: 10.1172/JCI7861.
Authors
G McGill
1
,
D E Fisher
Affiliation
1
Division of Pediatric Hematology/Oncology, Graduate Program in Biological and Biomedical Sciences, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
PMID:
10430602
PMCID:
PMC408427
DOI:
10.1172/JCI7861
No abstract available
Publication types
Comment
Review
MeSH terms
Animals
Colorectal Neoplasms / drug therapy*
Colorectal Neoplasms / pathology
Drug Resistance, Neoplasm*
Humans
Tumor Suppressor Protein p53 / physiology*
Substances
Tumor Suppressor Protein p53